Showing 1 - 3 results of 3 for search 'E. A. Shabalina', query time: 0.03s Refine Results
  1. 1
    Pharmacoeconomic analysis of tixagevimab and cilgavimab combination for COVID-19 therapy

    Pharmacoeconomic analysis of tixagevimab and cilgavimab combination for COVID-19 therapy by M. V. Zhuravleva, V. P. Chulanov, Yu. V. Gagarina, E. A. Shabalina

    Published 2023-07-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Cost-effectiveness of valsartan+sakubitril, dapagliflosin and empagliflosin for prevention of cardiovascular death and reducing cardiovascular mortality within the State Program "Health Development" in patients with heart failure

    Cost-effectiveness of valsartan+sakubitril, dapagliflosin and empagliflosin for prevention of cardiovascular death and reducing cardiovascular mortality within the State Program "H... by M. V. Zhuravleva, S. N. Tereshchenko, F. N. Paleev, Yu. V. Gagarina, E. A. Shabalina

    Published 2023-12-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Сost-effectiveness of preventing cardiovascular death and achieving the target indicator "Reduction of the cardiovascular mortality of the population" of the State Program "Health Development" when using valsartan+sacubitril, dapagliflozin and empagliflozin in patients with heart failure with reduced ejection fraction

    Сost-effectiveness of preventing cardiovascular death and achieving the target indicator "Reduction of the cardiovascular mortality of the population" of the State Program "Health... by M. V. Zhuravleva, S. N. Tereshchenko, I. V. Zhirov, S. V. Nedogoda, Yu. V. Gagarina, E. A. Shabalina

    Published 2023-04-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: